Naked Biome

Naked Biome is a pioneering microbiome-based skin therapeutics company focused on developing live biologic therapeutics for inflammatory skin diseases, principally acne. Utilizing a proprietary approach to skin therapy, the company is leveraging the power of beneficial bacteria to combat harmful bacteria and restore skin to a healthier state.

Founded in 2015, Naked Biome has made significant strides, including the successful completion of a Phase IB for its first indication, acne. This involved the testing of a topical live biologic therapeutic, showing positive safety and efficacy trends. These included favorable results in measures such as investigator global assessment of acne, lesion counts, and a shift to a healthy microbiome profile.

Operating within the Biotechnology, Health Care, Life Sciences, and Medical Devices industries, Naked Biome is at the forefront of innovative skin therapeutics. Despite a lack of recent publicized investment rounds or specific investors, the company's dedication to leveraging cutting-edge genomics in drug discovery for skin diseases positions it as a promising venture for potential venture capital interest. Hailing from the United States, Naked Biome is a compelling opportunity in the evolving landscape of biologic therapeutics.